From owner-chemistry@ccl.net Sun Jun 8 00:27:00 2008 From: "Mireille Krier mv.krier-$-googlemail.com" To: CCL Subject: CCL: agonist-antagonist-inhibitor Message-Id: <-37114-080605051228-24737-8HkSkQgTYHIV/8rk8x1ntA*server.ccl.net> X-Original-From: "Mireille Krier" Content-Type: multipart/alternative; boundary="----=_Part_282_16906866.1212653867539" Date: Thu, 5 Jun 2008 10:17:47 +0200 MIME-Version: 1.0 Sent to CCL by: "Mireille Krier" [mv.krier%googlemail.com] ------=_Part_282_16906866.1212653867539 Content-Type: text/plain; charset=ISO-8859-1 Content-Transfer-Encoding: 7bit Content-Disposition: inline Hi Mike, Landry and Gies in their recent review paper "Drugs and their molecular targets: an updated overview." bring it nicely to the point: http://www.ncbi.nlm.nih.gov/pubmed/18251718 Various ligands for a single target Most of the target types can be either stimulated or inhibited, depending on the ligand chosen. This leads to opposite regulations of related cellular functions. Terms used to characterize these different ligand types differ according to the biochemical nature of the targets. Enzyme ligands most often lead to inhibition of enzyme activity, binding to the active site with competition with the substrate (competitive inhibitors) or to allosteric sites (non-competitive inhibitors). Activation of an enzyme is more difficult, unless giving or generating an excess of substrate or co-substrate. Membrane transporters and ion channel permeability can be increased or decreased by direct binding of selected drugs termed 'openers' and 'inhibitors' (or blockers) respectively. However, such ligands are too often improperly referred to as 'agonists' and 'antagonists'*.* Receptors of mediators interact with a large diversity of ligand types. Agonists mimic the effects of endogenous mediators. Some exceptions to this concept are now known, some couples of mediators acting through the binding to a single receptor with agonist or antagonist properties, respectively, i.e. interleukin-1 and interleukin-1 receptor antagonist protein (IRAP), RANK-L and osteoprotegerin (OPG), melanocortin (MSH) and agouti-related protein (AGRP). Full agonists elicit a maximal response of the organism, usually similar to that of the mediator. Partial agonists elicit a partial response of the organism, and prevent the binding of the mediator. Thus the related function of the organism is decreased. Neutral antagonists prevent the binding of the mediator and thus abolish downstream physiological responses caused by the mediator. Inverse agonists, also termed 'negative antagonists', have been found among antagonists. Similar to neutral antagonists, they prevent the binding of agonists, including mediators, but elicit a response inverse to that of agonists. Such ligands decrease the constitutive activity of receptors [6,7 ]. Receptors of mediators including intrinsic ion channels or enzyme activity have ligands in their receptor part (agonists and antagonists) as well as in their ion channel (openers and inhibitors or blockers) or enzyme part (inhibitors). Hope this helps. Cheers, Mireille On 6/4/08, Michael Xu michael.drug.design ~~ gmail.com < owner-chemistry|ccl.net> wrote: > > Hi, all > > > > Recent days, some experts gave a wonderful explanation of IC50, Ki, Kd, and > deltaG. > > > > I am confused about some words several years. Can anyone give some > discussion? > > > > Inhibitor > > Agonist > > Antagonist > > Inverse agonist. > > > > Is the inhibitor used for Enzyme-substrate-inhibitor? > > And the agonist/antagonist used for protein-ligand? > > > > Thanks in advance. > > > > Mike. > ------=_Part_282_16906866.1212653867539 Content-Type: text/html; charset=ISO-8859-1 Content-Transfer-Encoding: quoted-printable Content-Disposition: inline
Hi Mike,
 
Landry and Gies in their recent review paper "Drugs and their mol= ecular targets: an updated overview." bring it nicely to the point:
http://www.ncb= i.nlm.nih.gov/pubmed/18251718
 

Various ligands for a single target

Most of the target types can be either stimulated or inhibited, dependin= g on the ligand chosen. This leads to opposite regulations of related cellu= lar functions. Terms used to characterize these different ligand types diff= er according to the biochemical nature of the targets.

Enzyme ligands most often lead to inhibition of enzyme activity, binding= to the active site with competition with the substrate (competitive inhibi= tors) or to allosteric sites (non-competitive inhibitors). Activation of an= enzyme is more difficult, unless giving or generating an excess of substra= te or co-substrate.

Membrane transporters and ion channel permeability can be increased or d= ecreased by direct binding of selected drugs termed 'openers' and 'inhibito= rs' (or blockers) respectively. However, such ligands are too often imprope= rly referred to as 'agonists' and 'antagonists'.

Receptors of mediators interact with a large diversity of ligand types. = Agonists mimic the effects of endogenous mediators. Some exceptions to this= concept are now known, some couples of mediators acting through the bindin= g to a single receptor with agonist or antagonist properties, respectively,= i.e. interleukin-1 and interleukin-1 receptor antagonist protein (IRAP), R= ANK-L and osteoprotegerin (OPG), melanocortin (MSH) and agouti-related prot= ein (AGRP). Full agonists elicit a maximal response of the organism, usuall= y similar to that of the mediator. Partial agonists elicit a partial respon= se of the organism, and prevent the binding of the mediator. Thus the relat= ed function of the organism is decreased. Neutral antagonists prevent the b= inding of the mediator and thus abolish downstream physiological responses = caused by the mediator. Inverse agonists, also termed 'negative antagonists= ', have been found among antagonists. Similar to neutral antagonists, they = prevent the binding of agonists, including mediators, but elicit a response= inverse to that of agonists. Such ligands decrease the constitutive activi= ty of receptors [6,7].=

Receptors of mediators including intrinsic ion channels o= r enzyme activity have ligands in their receptor part (agonists and antagon= ists) as well as in their ion channel (openers and inhibitors or blockers) = or enzyme part (inhibitors).

Hope this helps.
Cheers,
Mireille

 
On 6/4/08, M= ichael Xu michael.drug.design ~~ gmail.com= <owner-chemistry|ccl.net= > wrote:

H= i, all

 

Recent days, some experts gave a wonderful expl= anation of IC50, Ki, Kd, and deltaG.

 

I am confused about some words several years. C= an anyone give some discussion?

 

Inhibitor

Agonist

Antagonist

Inverse agonist.

 

Is the inhibitor used for Enzyme-substrate-inhi= bitor?

And the agonist/antagonist used for protein-lig= and?

 

Thanks in advance.

 

Mike.


------=_Part_282_16906866.1212653867539-- From owner-chemistry@ccl.net Sun Jun 8 01:52:00 2008 From: "Rajarshi Guha rguha!=!indiana.edu" To: CCL Subject: CCL: Code for clustering !! Message-Id: <-37115-080608011830-3148-61ExEcgEI6Yy2M6+alOZKA .. server.ccl.net> X-Original-From: Rajarshi Guha Content-Transfer-Encoding: 7bit Content-Type: text/plain; charset=US-ASCII; delsp=yes; format=flowed Date: Sun, 8 Jun 2008 01:18:06 -0400 Mime-Version: 1.0 (Apple Message framework v753.1) Sent to CCL by: Rajarshi Guha [rguha:_:indiana.edu] -----BEGIN PGP SIGNED MESSAGE----- Hash: SHA1 On Jun 6, 2008, at 12:27 AM, Pradipta Bandyopadhyay pradipta_b-*- mail.jnu.ac.in wrote: > > Sent to CCL by: "Pradipta Bandyopadhyay" [pradipta_b ~ mail.jnu.ac.in] > Dear All, > > I am looking for a fortran code (or 2 codes) for hierarchical > clustering and k-means clustering. I want to use it for > clustering molecules based on energy and/or geometrical parameters. > I would appreciate any pointer. R will do this (depending to some extent on the size of your dataset) - ------------------------------------------------------------------- Rajarshi Guha GPG Fingerprint: D070 5427 CC5B 7938 929C DD13 66A1 922C 51E7 9E84 - ------------------------------------------------------------------- Q: What is a dyslexic, agnostic, insomniac? A: Someone who lays awake at night wondering if there really is a dog! -----BEGIN PGP SIGNATURE----- Version: GnuPG v1.4.8 (Darwin) iEYEARECAAYFAkhLa44ACgkQZqGSLFHnnoQG9gCg7Z2kt+QQyqQx9z5ybF+yWCZ2 dVoAoOSnNoAey2++BjTnTmd62qcRcqOH =m1Yu -----END PGP SIGNATURE----- From owner-chemistry@ccl.net Sun Jun 8 02:28:00 2008 From: "Eric Scerri scerri|chem.ucla.edu" To: CCL Subject: CCL: New Book on Philosophy of Chemistry to be published in 3 days Message-Id: <-37116-080606120320-21767-PSxqBoH1970LiaAhDeZ3Ng_-_server.ccl.net> X-Original-From: Eric Scerri Content-Type: multipart/alternative; boundary=Apple-Mail-6-377454067 Date: Fri, 6 Jun 2008 06:52:51 -0700 Mime-Version: 1.0 (Apple Message framework v753.1) Sent to CCL by: Eric Scerri [scerri. _ .chem.ucla.edu] --Apple-Mail-6-377454067 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=WINDOWS-1252; delsp=yes; format=flowed Please see http://www.icpress.co.uk/chemistry/p548.html -------------l COLLECTED PAPERS ON PHILOSOPHY OF CHEMISTRY IMPERIAL COLLEGE PRESS. Publication Date June 9th, 2008. by Eric R Scerri (University of California in Los Angeles, USA) This book represents a collection of papers from one of the founders =20 of the new Philosophy of Chemistry. It is only the second single-=20 author collection of papers on the Philosophy of Chemistry. The author is the editor-in-chief of Foundations of Chemistry, the =20 leading journal in the field. He has recently gained worldwide =20 success with his book on the periodic table of the elements titled =20 The Periodic Table: Its Story and Its Significance. This volume =20 provides an in-depth examination of his more philosophical and =20 historical work in this area and further afield. Contents: * Philosophy of Chemistry and the Question of Reduction: * British Journal for Philosophy of Science, 1993? * The Case for Philosophy of Chemistry * Prediction of the Nature of Hafnium from Chemistry, Bohr=92s =20 Theory and Quantum Theory * Has Chemistry Been at Least Approximately Reduced to Quantum =20 Mechanics? * The Ontological Reduction of Chemistry * The Periodic Table, Electronic Configurations and the Nature =20 of the Elements: * Has the Periodic Table Been Successfully Axiomatized? * The Periodic Table: The Ultimate Paper Tool in Chemistry * Naive Realism, Reduction and the =91Intermediate Position=92 * How Ab Inito is Ab Initio Quantum Chemistry? Foundations of =20 Chemistry * Some Aspects of the Metaphysics of Chemistry and the Nature of =20= the Elements * Realism and Anti-Realism, and Educational Issues in Philosophy =20= of Chemistry: * Constructivism, Relativism and Chemistry * The Recently Claimed Observation of Atomic Orbitals and Some =20 Related Philosophical Issues * Normative and Descriptive Philosophy of Science and the Role =20 of Chemistry --Apple-Mail-6-377454067 Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=WINDOWS-1252

Please see





-------------l

COLLECTED PAPERS ON = PHILOSOPHY OF CHEMISTRY =A0 =A0 =A0= =A0

IMPERIAL COLLEGE PRESS. =A0
Publication Date June 9th, 2008.

by Eric R = Scerri (University of California in Los Angeles, USA)

This book = represents a collection of papers from one of the founders of the new = Philosophy of Chemistry. It is only the second single-author collection = of papers on the Philosophy of Chemistry.

The = author is the editor-in-chief of Foundations of Chemistry, the leading = journal in the field. He has recently gained worldwide success with his = book on the periodic table of the elements titled The Periodic Table: = Its Story and Its Significance. This volume provides an in-depth = examination of his more philosophical and historical work in this area = and further afield.


Contents:

=A0 =A0 * Philosophy of Chemistry and the Question of = Reduction:
=A0 =A0 * British Journal = for Philosophy of Science, 1993?
=A0 =A0 * = The Case for Philosophy of Chemistry
=A0 =A0 * = Prediction of the Nature of Hafnium from Chemistry, Bohr=92s Theory and = Quantum Theory
=A0 =A0 * Has Chemistry Been = at Least Approximately Reduced to Quantum Mechanics?
=A0 =A0 * The Ontological Reduction of = Chemistry
=A0 =A0 * The Periodic = Table, Electronic Configurations and the Nature of the = Elements:
=A0 =A0 * Has the Periodic = Table Been Successfully Axiomatized?
=A0 =A0 * = The Periodic Table: The Ultimate Paper Tool in = Chemistry
=A0 =A0 * Naive Realism, = Reduction and the =91Intermediate Position=92
=A0 =A0 * How Ab Inito is Ab Initio Quantum Chemistry? = Foundations of Chemistry
=A0 =A0 * = Some Aspects of the Metaphysics of Chemistry and the Nature of the = Elements
=A0 =A0 * Realism and = Anti-Realism, and Educational Issues in Philosophy of = Chemistry:
=A0 =A0 * Constructivism, = Relativism and Chemistry
=A0 =A0 * = The Recently Claimed Observation of Atomic Orbitals and Some Related = Philosophical Issues
=A0 =A0 * = Normative and Descriptive Philosophy of Science and the Role of = Chemistry=A0






= --Apple-Mail-6-377454067--